Company: CORT
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001628280-25-037005
Chunk: 207

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-07-31
Form: 10-Q
Item: Part I, Item 4
Chunk 207
---
 stock repurchase program (in thousands, except average price per share):

Fiscal PeriodTotal Number of Shares RepurchasedAverage Price Paid Per ShareDollar Amount of Shares That May Yet be Purchased Under the Program(1)April 1, 2025 to April 30, 2025— $— $156,896 May 1, 2025 to May 31, 2025275 70.10 137,656 June 1, 2025 to June 30, 20251,207 69.40 53,887 Total1,482 $69.53 $53,887 

(1) On January 8, 2024, our Board of Directors authorized the repurchase of up to $200 million of our common stock pursuant to our Stock Repurchase Program. The program may be modified, suspended or discontinued at any time without notice.

The following table contains information relating to the purchase of shares of our common stock in the three months ended June 30, 2025 as part of the cashless net exercises of stock options and vesting of restricted stock (in thousands, except average price per share):

Fiscal PeriodTotal Number of Shares Purchased(1)Average Price Per ShareTotal Purchase Price of Shares(2)April 1, 2025 to April 30, 202544 $75.65 $3,293 May 1, 2025 to May 31, 202565 73.66 4,800 June 1, 2025 to June 30, 2025153 72.78 11,128 Total262 $73.48 $19,221 

(1) In April 2025, we issued 90,524 shares of common stock as part of a net-share settlement of a cashless option exercise, of which 32,850 shares were surrendered to us in satisfaction of related exercise cost and tax obligations. In May 2025, we issued 108,494 shares of common stock as part of a net-share settlement of a cashless option exercise, of which 35,265 shares were surrendered to us. In June 2025, we issued 266,414 shares of common stock as part of a net-share settlement of a cashless option exercise, of which 129,315 shares were surrendered to us.

In April 2025, we issued 28,782 shares of common stock